
    
      -  In Treatment Period 1, subjects will receive a single 2 mg oral dose of midazolam.

        -  In Treatment Period 2, on Days 2-6, the same subjects will receive twice daily (BID)
           oral doses of 25 mg IPI-145; on Day 6, subjects will receive the morning dose of 25 mg
           IPI-145 concomitantly administered with 2 mg of midazolam.
    
  